title: Targeting Macrophages Boosts Pancreatic Cancer Therapy.
abstract: An inhibitor of monocyte recruitment shows little toxicity and boosts response to chemotherapy in patients with pancreatic cancer.
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors*; D018932:Chemokine CCL2 / Q000037:antagonists & inhibitors; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism*; D058990:Molecular Targeted Therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism*; D054390:Receptors, CCR2 / Q000037:antagonists & inhibitors
chemical_list: D014408:Biomarkers, Tumor; D018932:Chemokine CCL2; D054390:Receptors, CCR2